Who owns Enzo Biochem?
- Ticker: ENZ
- CUSIP Number: 294100102
Tip: Access positions for across all investors
Analyze quarterly positions in Enzo Biochem with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Enzo Biochem stock
Who bought or sold Enzo Biochem this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Harbert Fund Advisors | 5.2M | $7.2M | 0% | Sep 2023 |
|
Renaissance Technologies | 2.6M | $3.6M | -6% | Sep 2023 |
|
Vanguard Group | 1.9M | $2.6M | 9% | Dec 2023 |
|
Tang Capital Management | 1.7M | $2.4M | -23% | Dec 2023 |
|
Potomac Capital Management | 1.5M | $2.1M | 2% | Dec 2023 |
|
BlackRock | 955k | $1.3M | -4% | Sep 2023 |
|
Dimensional Fund Advisors | 730k | $1.0M | -13% | Dec 2023 |
|
Geode Capital Management | 338k | $473k | 0% | Sep 2023 |
|
Rbf Capital | 250k | $351k | 0% | Sep 2023 |
|
Bridgeway Capital Management | 227k | $318k | -27% | Sep 2023 |
|
State Street Corporation | 167k | $234k | 0% | Sep 2023 |
|
Northern Trust | 104k | $146k | 0% | Sep 2023 |
|
FNY Investment Advisers | 76k | $105k | 100% | Dec 2023 |
|
Morgan Stanley | 76k | $106k | 12% | Sep 2023 |
|
Assenagon Asset Management | 72k | $101k | -11% | Dec 2023 |
|
Lazard Asset Management | 51k | $70k | 0% | Dec 2023 |
|
T. Rowe Price Associates | 45k | $63k | 0% | Dec 2023 |
|
Bank of New York Mellon | 26k | $36k | 0% | Dec 2023 |
|
Kempner Capital Management | 26k | $35k | 0% | Dec 2023 |
|
Millennium Management | 25k | $35k | 100% | Dec 2023 |
|
Snowden Capital Advisors | 20k | $28k | -5% | Dec 2023 |
|
AE Wealth Management | 20k | $26k | 0% | Dec 2023 |
|
Paradigm Financial Partners | 20k | $27k | 0% | Dec 2023 |
|
Raymond James Trust | 17k | $24k | 0% | Dec 2023 |
|
Shulman DeMeo Asset Management | 16k | $22k | 0% | Dec 2023 |
|
Tower Research Capital | 16k | $22k | 56% | Sep 2023 |
|
Susquehanna International | 15k | $21k | 100% | Sep 2023 |
|
Sage Mountain Advisors | 14k | $20k | -39% | Dec 2023 |
|
Charles Schwab Investment Management | 14k | $19k | 0% | Dec 2023 |
|
Jane Street | 12k | $16k | 100% | Dec 2023 |
|
Nierenberg Investment Management Company | 12k | $16k | 100% | Dec 2023 |
|
Covestor | 4.0k | $6.0k | 0% | Dec 2023 |
|
Bank of America Corporation | 3.1k | $4.3k | 1% | Dec 2023 |
|
UBS Group | 1.9k | $2.6k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 1.8k | $2.5k | 0% | Dec 2023 |
|
Royal Bank of Canada | 1.3k | $0 | 21% | Dec 2023 |
|
Wells Fargo & Company | 1.3k | $1.8k | 2% | Dec 2023 |
|
Advisor Group Holdings | 1.1k | $1.6k | -35% | Dec 2023 |
|
Advisory Services Network | 500.00 | $695.000000 | 100% | Dec 2023 |
|
Benjamin Edwards | 300.00 | $0 | 0% | Dec 2023 |
|
FMR | 300.00 | $420.000000 | 100% | Sep 2023 |
|
Focused Wealth Management | 110.00 | $152.999000 | 0% | Dec 2023 |
|
Goss Wealth Management | 10.00 | $14.000000 | 0% | Sep 2023 |
|
Who sold out of Enzo Biochem?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Hanna Zanoni | Jun 2023 | 986k | $1.8M |
Roumell Asset Management | Jun 2023 | 681k | $1.3M |
Shay Capital | Sep 2023 | 63k | $88k |
Citadel Advisors | Sep 2023 | 61k | $85k |
Corsair Capital Management | Jun 2023 | 48k | $88k |
Nbc Securities | Sep 2023 | 2.5k | $3.0k |